Les Shaw

6.4k total citations
18 papers, 1.0k citations indexed

About

Les Shaw is a scholar working on Molecular Biology, Transplantation and Physiology. According to data from OpenAlex, Les Shaw has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Transplantation and 6 papers in Physiology. Recurrent topics in Les Shaw's work include Renal Transplantation Outcomes and Treatments (6 papers), Alzheimer's disease research and treatments (6 papers) and Dementia and Cognitive Impairment Research (4 papers). Les Shaw is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Alzheimer's disease research and treatments (6 papers) and Dementia and Cognitive Impairment Research (4 papers). Les Shaw collaborates with scholars based in United States, Sweden and Switzerland. Les Shaw's co-authors include John Q. Trojanowski, Bruce Kaplan, Paul Aisen, Clifford R. Jack, D. S. Knopman, Stephen D. Weigand, Matt A. Bernstein, H. Wiste, V. Shane Pankratz and Michael W. Weiner and has published in prestigious journals such as Brain, Neurology and Hypertension.

In The Last Decade

Les Shaw

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Les Shaw United States 10 443 434 251 157 143 18 1.0k
Fabio Minicucci Italy 24 334 0.8× 265 0.6× 49 0.2× 439 2.8× 169 1.2× 63 1.8k
P. Krupp Switzerland 17 262 0.6× 74 0.2× 28 0.1× 136 0.9× 102 0.7× 55 972
Ovidiu Băjenaru Romania 18 151 0.3× 137 0.3× 19 0.1× 138 0.9× 136 1.0× 53 1.5k
Yangmei Chen China 22 439 1.0× 83 0.2× 13 0.1× 365 2.3× 158 1.1× 99 1.4k
Christopher Büsch Germany 20 41 0.1× 144 0.3× 29 0.1× 812 5.2× 73 0.5× 55 2.1k
Simone Hoeger Germany 19 76 0.2× 39 0.1× 181 0.7× 121 0.8× 20 0.1× 33 817
Alessandro Príncipe Spain 15 233 0.5× 53 0.1× 9 0.0× 56 0.4× 227 1.6× 51 783
Suman Kushwaha India 19 211 0.5× 259 0.6× 4 0.0× 238 1.5× 69 0.5× 84 1.0k
Timothy R. Smith United States 19 842 1.9× 453 1.0× 5 0.0× 335 2.1× 152 1.1× 44 1.7k
Xiaodong Zhang China 15 73 0.2× 97 0.2× 16 0.1× 98 0.6× 111 0.8× 67 671

Countries citing papers authored by Les Shaw

Since Specialization
Citations

This map shows the geographic impact of Les Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Les Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Les Shaw more than expected).

Fields of papers citing papers by Les Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Les Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Les Shaw. The network helps show where Les Shaw may publish in the future.

Co-authorship network of co-authors of Les Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Les Shaw. A scholar is included among the top collaborators of Les Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Les Shaw. Les Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nilsson, Johanna, Katheryn A Q Cousins, Johan Gobom, et al.. (2021). A novel antibody‐free mass spectrometry panel of CSF biomarkers for synaptic dysfunction. Alzheimer s & Dementia. 17(S5). 2 indexed citations
2.
Cousins, Katheryn A Q, Sarah Burke, David J. Irwin, et al.. (2021). Cerebrospinal fluid neurogranin in non‐amnestic and amnestic Alzheimer’s disease. Alzheimer s & Dementia. 17(S5). 1 indexed citations
3.
Grossman, Murray, Lauren Elman, Leo McCluskey, et al.. (2014). Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis. JAMA Neurology. 71(4). 442–442. 69 indexed citations
4.
Hu, William T., Alice Chen‐Plotkin, Owen A. Ross, et al.. (2010). Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology. 75(23). 2079–2086. 74 indexed citations
5.
Zetterberg, Henrik, Niklas Mattsson, Les Shaw, & Kaj Blennow. (2010). Biochemical Markers in Alzheimer's Disease Clinical Trials. Biomarkers in Medicine. 4(1). 91–98. 14 indexed citations
6.
Jack, Clifford R., H. Wiste, Prashanthi Vemuri, et al.. (2010). Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain. 133(11). 3336–3348. 391 indexed citations
7.
Quinn, Joseph F., Ronald G. Thomas, Rema Raman, et al.. (2010). P1‐447: Cerebrospinal fluid biomarker outcomes in a trial of docosahexaenoic acid (DHA) for Alzheimer's disease. Alzheimer s & Dementia. 6(4S_Part_10). 1 indexed citations
8.
Hampel, Harald, Yong Shen, Dominic M. Walsh, et al.. (2009). Biological markers of amyloid β-related mechanisms in Alzheimer's disease. Experimental Neurology. 223(2). 334–346. 131 indexed citations
9.
Gaston, Robert S., Bruce Kaplan, T. Shah, et al.. (2009). Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial. American Journal of Transplantation. 9(7). 1607–1619. 141 indexed citations
10.
Heerkens, Egidius H.J., Les Shaw, Ashley S. Izzard, et al.. (2004). Integrins in hypertension mediated eutrophic remodelling of tgr(REN2)27 rat arteries. Hypertension. 44(4). 505–505. 1 indexed citations
11.
MacFarlane, Gordon D., et al.. (1999). ANALYSIS OF WHOLE BLOOD TACROLIMUS CONCENTRATIONS IN LIVER TRANSPLANT PATIENTS EXHIBITING CHOLESTASIS WITH THE PRO-TRAC™ II ELISA.. Therapeutic Drug Monitoring. 21(4). 437–437. 2 indexed citations
12.
Kaplan, Bruce, et al.. (1998). DECREASED PROTEIN BINDING OF MYCOPHENOLIC ACID ASSOCIATED WITH LEUKOPENIA IN A PANCREAS TRANSPLANT RECIPIENT WITH RENAL FAILURE. Transplantation. 65(8). 1127–1129. 68 indexed citations
13.
Cooney, Gerard F., et al.. (1996). Tacrolimus Pharmacokinetics (PK) in Renal TXP Candidates Using a Sensitive Assay. Clinical Pharmacology & Therapeutics. 59(2). 215–215. 1 indexed citations
14.
Heifets, Michael, et al.. (1995). Diurnal variation of cyclosporine clearance in stable renal transplant recipients receiving continuous infusion.. PubMed. 60(12). 1615–7. 9 indexed citations
15.
Cooney, Gerard F., et al.. (1994). Utility of Pretransplantion Cyclosporine Pharmacokinetic Studies. Therapeutic Drug Monitoring. 16(2). 151–154. 8 indexed citations
16.
Cooney, Gerard F., Stanley B. Fiel, Les Shaw, & Nicholas C. Cavarocchi. (1990). Cyclosporine bioavailability in heart-lung transplant candidates with cystic fibrosis.. PubMed. 49(4). 821–3. 41 indexed citations
17.
Shaw, Les. (1989). Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring.. Clinical Chemistry. 35(7). 1299–1308. 67 indexed citations
18.
Brayman, Kenneth L., J Armstrong, Les Shaw, et al.. (1987). Prevention of diabetes in BB rats by intermittent administration of cyclosporine.. PubMed. 102(2). 235–41. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026